Groupe la Francaise Lowers Position in Danaher Corporation $DHR

Key Points

• Groupe la Francaise reduced its Danaher stake by 21.8% in the second quarter, selling 7,414 shares and retaining 26,621 shares valued at approximately $5.07 million.
• Analysts remain broadly bullish, with Danaher receiving a “Moderate Buy” consensus rating and an average price target of $228.91, above its reported opening price of $207.46.
• Danaher exceeded quarterly expectations, reporting $1.94 in adjusted EPS versus the $1.85 consensus and revenue of $6.26 billion, up 5.5% year over year.

Groupe la Francaise cut its position in shares of Danaher Corporation (NYSE:DHR - Free Report) by 21.8% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 26,621 shares of the conglomerate's stock after selling 7,414 shares during the quarter. Groupe la Francaise's holdings in Danaher were worth $5,070,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Hilton Head Capital Partners LLC purchased a new position in Danaher during the fourth quarter valued at $27,000. Clal Insurance Enterprises Holdings Ltd grew its position in shares of Danaher by 71.6% in the 4th quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate's stock worth $29,000 after buying an additional 53 shares during the period. JPL Wealth Management LLC bought a new position in shares of Danaher in the 3rd quarter worth about $25,000. N.E.W. Advisory Services LLC bought a new position in shares of Danaher in the 2nd quarter worth about $25,000. Finally, Main Street Group LTD purchased a new position in Danaher during the 1st quarter valued at about $25,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

DHR has been the topic of several research reports. Royal Bank Of Canada boosted their price objective on shares of Danaher from $200.00 to $215.00 and gave the stock an "outperform" rating in a research note on Wednesday, July 22nd. Wolfe Research lowered shares of Danaher from an "outperform" rating to a "peer perform" rating in a report on Monday, June 1st. Deutsche Bank Aktiengesellschaft reissued a "buy" rating and issued a $240.00 price target on shares of Danaher in a research report on Wednesday, July 22nd. Evercore restated an "outperform" rating and issued a $230.00 price target on shares of Danaher in a research note on Monday, July 6th. Finally, TD Cowen reduced their price objective on Danaher from $240.00 to $236.00 and set a "buy" rating for the company in a research report on Wednesday, July 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $228.91.

Danaher Stock Down 0.1%

Shares of Danaher stock opened at $207.46 on Tuesday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. The stock has a market capitalization of $145.84 billion, a PE ratio of 36.85, a price-to-earnings-growth ratio of 2.59 and a beta of 0.78. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The company has a 50-day simple moving average of $202.03 and a two-hundred day simple moving average of $192.15.

Danaher (NYSE:DHR - Get Free Report) last issued its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.85 by $0.09. The firm had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business's revenue was up 5.5% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.77 earnings per share. On average, analysts anticipate that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Danaher Profile

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.